Contents
pdf Download PDF
pdf Download XML
317 Views
15 Downloads
Share this article
Research Article | Volume: 28 Issue 1 (Jan-Dec, 2023) | Pages 1 - 3
Drug-Eluting Stents: Long-Term Outcomes and Innovations in Stent Design
1
Division of Interventional Cardiology, Cleveland Clinic
Under a Creative Commons license
Open Access
Published
Sept. 19, 2023
Abstract

Drug-eluting stents (DES) have revolutionized the treatment of coronary artery disease (CAD), significantly reducing the incidence of restenosis compared to bare-metal stents (BMS). Advances in stent technology, including improvements in polymer coatings, drug-elution profiles, and stent platforms, have enhanced long-term outcomes. This review focuses on the long-term efficacy and safety of DES, highlighting innovations in stent design and materials that aim to further reduce the risks of late restenosis, stent thrombosis, and the need for repeat revascularization. Challenges such as late stent thrombosis, dual antiplatelet therapy (DAPT) duration, and the emergence of bioresorbable stents are also discussed.

Keywords
Recommended Articles
Research Article
Study of Thyroid Dysfunction among Hiv Infected Patients on Highly Active Anti-Retroviral Therapy (Haart): A Cross-Sectional Study
Published: 30/01/2025
Research Article
The Use of 3D Echocardiography in Complex Congenital Heart Disease
Published: 25/10/2022
Research Article
Plasma Adiponectin and Its Role In Coronary Artery Disease: Review Article
...
Published: 25/10/2020
Research Article
Clinical Study of Factors Influencing the Outcome of Typhoid Ileal Perforation
...
Published: 25/10/2020
© Copyright Dialogues in Cardiovascular Medicine